LeMaitre Vascular (LMAT) EPS Drops ~70% at Roth Capital
Tweet Send to a Friend
Roth Capital analyst David Solomon reiterated a Neutral rating and lowered the price target to $28.00 (from $32.50) on LeMaitre ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


